Poor antibiotic prescribing practices are putting patients at risk for allergic reactions, super-resistant infections, and deadly diarrhea cause by Clostridium difficile, according to new report from the Centers for Disease Control and Prevention (CDC).
Poor antibiotic prescribing practices are putting patients at risk for allergic reactions, super-resistant infections, and deadly diarrhea cause by Clostridiumdifficile, according to new report from the Centers for Disease Control and Prevention (CDC).
The CDC report said the inconsistent prescribing practices are also driving antibiotic resistance and that antibiotic prescribing practices need to be changed immediately.
According to the report:
To help hospitals improve in the area of antibiotic prescribing, CDC developed a checklist of core safety elements that each facility should have in place. CDC said every hospital should have an antibiotic stewardship program. That program should include the following elements:
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More